Mycobacterium tuberculosis Cpn60.2 (GroEL2) blocks macrophage apoptosis via interaction with mitochondrial mortalin

Sunil Joseph1, Alex Yuen1, Vijender Singh1

  • 1Division of Infectious Diseases, Department of Medicine, Vancouver Costal Health Research Institute, University of British Columbia, Vancouver, British Columbia V6H 3Z6, Canada.

Biology Open
|March 15, 2017
PubMed

Insights

Mycobacterium tuberculosis (Mtb) protein Cpn60.2 inhibits macrophage apoptosis by interacting with host mortalin. This interaction promotes Mtb survival within macrophages, offering a new therapeutic target for tuberculosis.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Mycobacterium tuberculosis (Mtb) pathogenesis involves proteins exported into host macrophages.
  • Mtb proteins disrupt macrophage functions like phagolysosome fusion and antigen presentation, aiding intracellular persistence.
  • Cpn60.2, an abundant Mtb chaperone, is crucial for bacterial growth and located on the bacterial surface and cytoplasm.

Purpose of the Study:

  • To investigate the function of Mtb Cpn60.2 after macrophage ingestion.
  • To determine the interaction of Cpn60.2 with host cell components and its effect on macrophage apoptosis.

Main Methods:

  • Tracking Cpn60.2 localization within macrophages post-Mtb ingestion.
  • Investigating Cpn60.2 interaction with mitochondrial mortalin.
  • Assessing the impact of Cpn60.2 on macrophage apoptosis using mortalin inhibitors.

Main Results:

  • Mtb Cpn60.2 detaches from the bacterial surface and enters macrophage mitochondria.
  • Cpn60.2 interacts with host mortalin, a protein involved in apoptosis regulation.
  • Cpn60.2 inhibits macrophage apoptosis; this effect is reversed by mortalin inhibitors.

Conclusions:

  • Mtb Cpn60.2 possesses significant anti-apoptotic activity mediated by its interaction with mitochondrial mortalin.
  • This Cpn60.2-mortalin interaction enhances Mtb survival within the macrophage.
  • Targeting this interaction could be a novel strategy for tuberculosis treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.4K